BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 11367342)

  • 1. Topical 5-FU reduces CIN recurrence.
    Newsline People AIDS Coalit N Y; 1999; ():31. PubMed ID: 11367342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial.
    Maiman M; Watts DH; Andersen J; Clax P; Merino M; Kendall MA
    Obstet Gynecol; 1999 Dec; 94(6):954-61. PubMed ID: 10576182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina.
    Pride GL; Chuprevich TW
    Obstet Gynecol; 1982 Oct; 60(4):467-72. PubMed ID: 7121934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina.
    Krebs HB
    Obstet Gynecol; 1986 Dec; 68(6):837-41. PubMed ID: 3785797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer agents. Cream reduces reappearance of cervical lesions.
    TreatmentUpdate; 2000 Feb; 12(1):5-6. PubMed ID: 12125629
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions.
    Krebs HB; Helmkamp BF
    Obstet Gynecol; 1991 Aug; 78(2):205-8. PubMed ID: 1648696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High recurrence rate of cervical dysplasia and persistence of HPV infection in HIV-1-infected women.
    Gingelmaier A; Grubert T; Kaestner R; Mylonas I; Weissenbacher T; Bergauer F; Barthell L; Friese K
    Anticancer Res; 2007; 27(4A):1795-8. PubMed ID: 17649775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 5-fluorouracil in the treatment of intraepithelial neoplasia of the vagina.
    Ballon SC; Roberts JA; Lagasse LD
    Obstet Gynecol; 1979 Aug; 54(2):163-6. PubMed ID: 460749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-FU for maintenance therapy of cervical lesions.
    Hanna L
    BETA; 1999 Apr; 12(2):17. PubMed ID: 11366681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions.
    Niwa K; Tagami K; Lian Z; Gao J; Mori H; Tamaya T
    Oncol Rep; 2003; 10(5):1437-41. PubMed ID: 12883720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 5-fluorouracil treatment of vaginal intraepithelial neoplasia.
    Caglar H; Hertzog RW; Hreshchyshyn MM
    Obstet Gynecol; 1981 Nov; 58(5):580-3. PubMed ID: 7301233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions].
    Georgiev D; Karag'ozov I; Velev M; Makaveeva V
    Akush Ginekol (Sofiia); 2006; 45(3):59-61. PubMed ID: 16889191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorouracil/chemosurgery for intraepithelial neoplasia of the lower genital tract.
    Sillman FH; Boyce JG; Macasaet MA; Nicastri AD
    Obstet Gynecol; 1981 Sep; 58(3):356-60. PubMed ID: 7266956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
    Prabhasawat P; Tesavibul N; Leelapatranura K; Phonjan T
    Ophthalmology; 2006 Jul; 113(7):1102-9. PubMed ID: 16730066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of adjuvant self-administered intravaginal 5-fluorouracil cream following primary treatment of cervical intraepithelial neoplasia grade 2 or 3 among women living with HIV in Kenya: study protocol for a pilot trial.
    Mungo C; Bukusi E; Kirkland GE; Ogollah C; Rota G; Omoto J; Rahangdale L
    medRxiv; 2023 Dec; ():. PubMed ID: 38168442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
    Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-FU for cervical intraepithelia neoplasia.
    AIDS Patient Care STDS; 2000 Feb; 14(2):104. PubMed ID: 10743527
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of commercially available biological agents for the topical treatment of cervical intraepithelial neoplasia: a systematic review.
    Mutombo AB; Simoens C; Tozin R; Bogers J; Van Geertruyden JP; Jacquemyn Y
    Syst Rev; 2019 Jun; 8(1):132. PubMed ID: 31174598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 5-fluorouracil in the treatment of vaginal intraepithelial neoplasia.
    Kirwan P; Naftalin NJ
    Br J Obstet Gynaecol; 1985 Mar; 92(3):287-91. PubMed ID: 3978059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.